tallózása szerző szerint "Escher JC"

1-4 / 4

Diagnostic Workup of Paediatric Patients with Inflammatory Bowel Disease in Europe: Results of a 5-Year Audit of the EUROKIDS Registry

de Bie CI; Buderus S; Sandhu BK; de Ridder L; Paerregaard A; Veres, Gábor; Dias JA; Escher JC; the EUROKIDS Porto IBD Working Group of ESPGHAN (2012)

OBJECTIVE: In 2005, the Inflammatory Bowel Disease (IBD) Working Group of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition published consensus guidelines on the diagnostic workup of paediatric ...
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents.

Levine A; Koletzko S; Turner D; Escher JC; Cucchiara S; de Ridder L; Kolho KL; Veres, Gábor; Russell RK; Paerregaard A; Buderus S; Greer ML; Dias JA; Veereman-Wauters G; Lionetti P; Sladek M; Carpi JM; Staiano A; Ruemmele FM; Wilson DC (2014)

BACKGROUND:: The diagnosis of pediatric-onset IBD (PIBD) can be challenging in choosing the most informative diagnostic tests and correctly classifying PIBD into its different subtypes. Recent advances in our understanding ...
Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.

Ruemmele FM; Hyams JS; Otley A; Griffiths A; Kolho KL; Dias JA; Levine A; Escher JC; Taminiau J; Veres, Gábor; Colombel JF; Vermeire S; Wilson DC; Turner D (2015)

OBJECTIVE: Although paediatric-onset IBD is becoming more common, few medications have a registered paediatric indication. There are multiple hurdles to performing clinical trials in children, emphasising the importance ...
Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto group commentary

Veereman-Wauters G; De Ridder L; Veres, Gábor; Kolacek S; Fell J; Malmborg P; Koletzko S; Dias JA; Misak Z; Rahier J-F; Escher JC; ESPGHAN IBD Porto Group (2012)

Combined immunosuppression by immunomodulators and biological therapy has become standard in the medical management of moderate-tosevere inflammatory bowel disease (IBD) because of clearly demonstrated efficacy. Clinical ...

1-4 / 4

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Escher JC"

DSpace/Manakin Repository

tallózása szerző szerint "Escher JC"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem